CoChat
Sign Up
Cited by 277

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Food Allergies: The Basics

Valenta, Rudolf, Hochwallner, Heidrun, Linhart, Birgit, Pahr, Sandra·2015·Gastroenterology
DOI 10.1053/j.gastro.2015.02.006PMC PMC4414527
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2015.02.006

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Figures

Rudolf Valenta
Rudolf ValentaCC BY · PubMed Central
Heidrun Hochwallner
Heidrun HochwallnerCC BY · PubMed Central
Birgit Linhart
Birgit LinhartCC BY · PubMed Central
Sandra Pahr
Sandra PahrCC BY · PubMed Central
Figure 1 Classification of food intolerance. Adverse reactions to food can be classified as toxic or nontoxic reactions. Nontoxic reactions are categorized further as immune-mediated or non–immune-mediated. The most common adverse reactions are based on non–immune-mediated mechanisms such as enzyme defects as observed in lactose intolerance. Hypersensitivities involving the adaptive immune system can be subdivided into 4 categories (types I–IV). Type I reactions are always associated with the formation of IgE against food allergens and therefore can be called IgE-associated food allergies. There is firm evidence for an involvement of IgG in type II or type III reactions in immune-mediated adverse reactions to food, whereas type IV reactions, which involve T cells, have important roles in disorders such as celiac disease. There is evidence that the innate immune system, which includes complement, Toll-like receptors, and innate immune cells, also mediates immune reactions against certain food components.
Figure 1 Classification of food intolerance. Adverse reactions to food can be classified as toxic or nontoxic reactions. Nontoxic reactions are categorized further as immune-mediated or non–immune-mediated. The most common adverse reactions are based on non–immune-mediated mechanisms such as enzyme defects as observed in lactose intolerance. Hypersensitivities involving the adaptive immune system can be subdivided into 4 categories (types I–IV). Type I reactions are always associated with the formation of IgE against food allergens and therefore can be called IgE-associated food allergies. There is firm evidence for an involvement of IgG in type II or type III reactions in immune-mediated adverse reactions to food, whereas type IV reactions, which involve T cells, have important roles in disorders such as celiac disease. There is evidence that the innate immune system, which includes complement, Toll-like receptors, and innate immune cells, also mediates immune reactions against certain food components.CC BY · PubMed Central
Figure 2 Time course, pathogenesis, and manifestations of food allergies. IgE-associated food allergies appear to develop early in childhood. This process is termed allergic sensitization. (A) Allergen contact via the gastrointestinal tract, via the respiratory tract, and eventually via the skin induces IgE production (primary sensitization) in genetically predisposed individuals. Repeated allergen contact activates allergen-specific T cells and induces IgE responses during the secondary immune response. Factors that affect the epithelial barrier (red arrows) and the extent to which allergens are digested or degraded are important for primary sensitization and boosting of secondary immune responses. SIgA and T-regulatory cells may be important for exclusion of allergens from the intestinal lumen and induction of tolerance, respectively. (B) The balance between allergen-specific IgE and blocking IgG helps determine whether or not a patient will develop symptoms. Allergen avoidance could reduce levels of allergen-specific IgE to below the threshold for symptom induction (lower panel), whereas exposure could increase production of IgE, leading to symptoms (upper panel). If allergen exposure induces allergen-specific IgG, which blocks the interaction between the allergen and IgE, then symptoms might be reduced (middle panel). (C) Allergy symptoms are caused by repeated contact with the oral allergen, via the immediate allergic reaction (allergen-induced cross-linking of mast cell–bound IgE by allergen and then activation of allergen-specific T cells), and then by other inflammatory cells, such as eosinophils and basophils, during late-phase and chronic inflammation. Factors that affect the epithelial barrier and the extent of allergen degradation affect the amount of allergen intrusion and the magnitude and type of inflammation. After allergen ingestion, inflammation develops not only in the intestine, but in other organs, such as the skin, respiratory tract, and circulatory system (right). These allergens and allergen fragments are internalized and distributed throughout the body (left). MHC, major histocompatibility complex; T-reg, T-regulatory cell; TCR, T-cell receptor.
Figure 2 Time course, pathogenesis, and manifestations of food allergies. IgE-associated food allergies appear to develop early in childhood. This process is termed allergic sensitization. (A) Allergen contact via the gastrointestinal tract, via the respiratory tract, and eventually via the skin induces IgE production (primary sensitization) in genetically predisposed individuals. Repeated allergen contact activates allergen-specific T cells and induces IgE responses during the secondary immune response. Factors that affect the epithelial barrier (red arrows) and the extent to which allergens are digested or degraded are important for primary sensitization and boosting of secondary immune responses. SIgA and T-regulatory cells may be important for exclusion of allergens from the intestinal lumen and induction of tolerance, respectively. (B) The balance between allergen-specific IgE and blocking IgG helps determine whether or not a patient will develop symptoms. Allergen avoidance could reduce levels of allergen-specific IgE to below the threshold for symptom induction (lower panel), whereas exposure could increase production of IgE, leading to symptoms (upper panel). If allergen exposure induces allergen-specific IgG, which blocks the interaction between the allergen and IgE, then symptoms might be reduced (middle panel). (C) Allergy symptoms are caused by repeated contact with the oral allergen, via the immediate allergic reaction (allergen-induced cross-linking of mast cell–bound IgE by allergen and then activation of allergen-specific T cells), and then by other inflammatory cells, such as eosinophils and basophils, during late-phase and chronic inflammation. Factors that affect the epithelial barrier and the extent of allergen degradation affect the amount of allergen intrusion and the magnitude and type of inflammation. After allergen ingestion, inflammation develops not only in the intestine, but in other organs, such as the skin, respiratory tract, and circulatory system (right). These allergens and allergen fragments are internalized and distributed throughout the body (left). MHC, major histocompatibility complex; T-reg, T-regulatory cell; TCR, T-cell receptor.CC BY · PubMed Central
Figure 3 Diagnosis and management of IgE-associated food allergies. The diagnosis of a food allergy involves a case history and a demonstration of allergen-specific IgE production. Provocation tests and diets are used to identify disease-causing allergens. Based on this information, allergen-specific forms of treatment can be selected. This approach currently is being introduced into clinical practice. CFSE, carboxyfluorescein succinimidyl ester; ELISA, enzyme-linked immunosorbent assay; RBL, rat basophilic leukemia.
Figure 3 Diagnosis and management of IgE-associated food allergies. The diagnosis of a food allergy involves a case history and a demonstration of allergen-specific IgE production. Provocation tests and diets are used to identify disease-causing allergens. Based on this information, allergen-specific forms of treatment can be selected. This approach currently is being introduced into clinical practice. CFSE, carboxyfluorescein succinimidyl ester; ELISA, enzyme-linked immunosorbent assay; RBL, rat basophilic leukemia.CC BY · PubMed Central
Figure 4 Component-resolved diagnosis of a food allergy. Different sources of food allergens contain several allergenic molecules (components); these can be produced as recombinant proteins or purified from natural sources. These allergens can be classified into IgE-reactive components (green), which are poor activators of inflammatory cells and therefore induce little or no clinical reactions; components that induce mild or mainly local symptoms (yellow); and components that often are associated with severe and systemic allergic reactions (red). Microarray technology can be used to determine reactivity profiles of patients. This process can be used to identify individual allergens that cause disease and foods to which patients are most likely to respond. The severity of reactions also can be predicted.
Figure 4 Component-resolved diagnosis of a food allergy. Different sources of food allergens contain several allergenic molecules (components); these can be produced as recombinant proteins or purified from natural sources. These allergens can be classified into IgE-reactive components (green), which are poor activators of inflammatory cells and therefore induce little or no clinical reactions; components that induce mild or mainly local symptoms (yellow); and components that often are associated with severe and systemic allergic reactions (red). Microarray technology can be used to determine reactivity profiles of patients. This process can be used to identify individual allergens that cause disease and foods to which patients are most likely to respond. The severity of reactions also can be predicted.CC BY · PubMed Central
Figure 5 Allergen-specific forms of prophylaxis and treatment. Multiplex allergen systems can be used to identify disease-relevant food allergens in populations. (A) Based on the mapping of antigen epitopes recognized by patients’ IgE and T cells, 4 molecular approaches are being developed for prophylaxis and treatment. These are as follows: recombinant wild-type allergens, carrier-bound B-cell epitope–containing peptides (which do not react with IgE, have reduced allergen-specific epitopes recognized by T cells, and induce allergen-specific IgG), recombinant hypoallergens (which have reduced reactivity with IgE and fewer epitopes that interact with T cells, and induce allergen-specific IgG), and peptide epitopes that interact with T cells (but do not react with IgE or induce allergen-specific IgG). (B) Allergen-specific treatment can be prophylactic (prenatal or early postnatal) or be given after sensitization has taken place (specific immunotherapy). Active vaccination, passive immunization with allergen-specific antibodies, and tolerance induction are options.
Figure 5 Allergen-specific forms of prophylaxis and treatment. Multiplex allergen systems can be used to identify disease-relevant food allergens in populations. (A) Based on the mapping of antigen epitopes recognized by patients’ IgE and T cells, 4 molecular approaches are being developed for prophylaxis and treatment. These are as follows: recombinant wild-type allergens, carrier-bound B-cell epitope–containing peptides (which do not react with IgE, have reduced allergen-specific epitopes recognized by T cells, and induce allergen-specific IgG), recombinant hypoallergens (which have reduced reactivity with IgE and fewer epitopes that interact with T cells, and induce allergen-specific IgG), and peptide epitopes that interact with T cells (but do not react with IgE or induce allergen-specific IgG). (B) Allergen-specific treatment can be prophylactic (prenatal or early postnatal) or be given after sensitization has taken place (specific immunotherapy). Active vaccination, passive immunization with allergen-specific antibodies, and tolerance induction are options.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 129

  1. Sicherer, 2014, Food allergy: epidemiology, pathogenesis, diagnosis, and treatment, J Allergy Clin Immunol, 133, 291, 10.1016/j.jaci.2013.11.020 · DOI
  2. Longo, 2013, IgE-mediated food allergy in children, Lancet, 382, 1656, 10.1016/S0140-6736(13)60309-8 · DOI
  3. De Silva, 2014, Acute and long-term management of food allergy: systematic review, Allergy, 69, 159, 10.1111/all.12314 · DOI
  4. Boyce, 2010, Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report, J Allergy Clin Immunol, 126, 1105, 10.1016/j.jaci.2010.10.008 · DOI
  5. Von Pirquet, 1906, Allergie, Mnch Med Wochenschrift, 30, 1457
  6. Stapel, 2008, Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report, Allergy, 63, 793, 10.1111/j.1398-9995.2008.01705.x · DOI · Paper page
  7. Bock, 2010, AAAAI support of the EAACI position paper on IgG4, J Allergy Clin Immunol, 125, 1410, 10.1016/j.jaci.2010.03.013 · DOI
  8. Schuppan, 2009, Celiac disease: from pathogenesis to novel therapies, Gastroenterology, 137, 1912, 10.1053/j.gastro.2009.09.008 · DOI
  9. Caubet, 2014, Clinical features and resolution of food protein-induced enterocolitis syndrome: 10-year experience, J Allergy Clin Immunol, 134, 382, 10.1016/j.jaci.2014.04.008 · DOI
  10. Junker, 2012, Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4, J Exp Med, 209, 2395, 10.1084/jem.20102660 · DOI
  11. Kurakevich, 2013, Milk oligosaccharide sialyl(α2,3)lactose activates intestinal CD11c+ cells through TLR4, Proc Natl Acad Sci U S A, 110, 17444, 10.1073/pnas.1306322110 · DOI
  12. Catassi, 2013, Non-celiac gluten sensitivity: the new frontier of gluten related disorders, Nutrients, 5, 3839, 10.3390/nu5103839 · DOI
  13. Burney, 2014, The prevalence and distribution of food sensitization in European adults, Allergy, 69, 365, 10.1111/all.12341 · DOI
  14. Lack, 2012, Update on risk factors for food allergy, J Allergy Clin Immunol, 129, 1187, 10.1016/j.jaci.2012.02.036 · DOI · Paper page
  15. Gray, 2014, Food allergy in South African children with atopic dermatitis, Pediatr Allergy Immunol, 25, 572, 10.1111/pai.12270 · DOI
  16. Baumann, 2013, Obesity-a promoter of allergy?, Int Arch Allergy Immunol, 162, 205, 10.1159/000353972 · DOI
  17. Marrs, 2013, Is there an association between microbial exposure and food allergy? A systematic review, Pediatr Allergy Immunol, 24, 311, 10.1111/pai.12064 · DOI
  18. Martino, 2014, Epigenome-wide association study reveals longitudinally stable DNA methylation differences in CD4+ T cells from children with IgE-mediated food allergy, Epigenetics, 9, 998, 10.4161/epi.28945 · DOI
  19. Alm, 2002, An anthroposophic lifestyle and intestinal microflora in infancy, Pediatr Allergy Immunol, 13, 402, 10.1034/j.1399-3038.2002.01062.x · DOI
  20. Valenta, 2002, The future of antigen-specific immunotherapy of allergy, Nat Rev Immunol, 2, 446, 10.1038/nri824 · DOI
  21. Valenta, 2004, Immunotherapy of allergic disease, Adv Immunol, 82, 105, 10.1016/S0065-2776(04)82003-0 · DOI
  22. Han, 2012, Food allergy, Korean J Pediatr, 55, 153, 10.3345/kjp.2012.55.5.153 · DOI
  23. Ortolani, 1988, The oral allergy syndrome, Ann Allergy, 61, 47
  24. Valenta, 1996, Type 1 allergic reactions to plant-derived food: a consequence of primary sensitization to pollen allergens, J Allergy Clin Immunol, 97, 893, 10.1016/S0091-6749(96)80062-5 · DOI
  25. Bartnikas, 2013, Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis, J Allergy Clin Immunol, 131, 451, 10.1016/j.jaci.2012.11.032 · DOI
  26. Noti, 2014, Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis, J Allergy Clin Immunol, 133, 1390, 10.1016/j.jaci.2014.01.021 · DOI
  27. Asero, 2011, Does sensitization to foods in adults occur always in the gut?, Int Arch Allergy Immunol, 154, 6, 10.1159/000319203 · DOI
  28. Astwood, 1996, Stability of food allergens to digestion in vitro, Nat Biotechnol, 14, 1269, 10.1038/nbt1096-1269 · DOI
  29. Groschwitz, 2009, Intestinal barrier function: molecular regulation and disease pathogenesis, J Allergy Clin Immunol, 124, 3, 10.1016/j.jaci.2009.05.038 · DOI · Paper page
  30. Perrier, 2011, Gut permeability and food allergies, Clin Exp Allergy, 41, 20, 10.1111/j.1365-2222.2010.03639.x · DOI
  31. Johansen, 1999, Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice, J Exp Med, 190, 915, 10.1084/jem.190.7.915 · DOI
  32. Karlsson, 2010, Hypersensitivity and oral tolerance in the absence of a secretory immune system, Allergy, 65, 561, 10.1111/j.1398-9995.2009.02225.x · DOI
  33. Grammatikos, 2008, The genetic and environmental basis of atopic diseases, Ann Med, 40, 482, 10.1080/07853890802082096 · DOI
  34. Paul, 1987, Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions, FASEB J, 1, 456, 10.1096/fasebj.1.6.3315808 · DOI
  35. Romagnani, 1997, The Th1/Th2 paradigm, Immunol Today, 18, 263, 10.1016/S0167-5699(97)80019-9 · DOI
  36. Vercelli, 1992, Regulation of isotype switching, Curr Opin Immunol, 4, 794, 10.1016/0952-7915(92)90064-L · DOI
  37. Henderson, 1975, Maximal rise in IgE antibody following ragweed pollination season, J Allergy Clin Immunol, 55, 10, 10.1016/S0091-6749(75)80003-0 · DOI
  38. Naclerio, 1997, Nasal provocation with allergen induces a secondary serum IgE antibody response, J Allergy Clin Immunol, 100, 505, 10.1016/S0091-6749(97)70143-X · DOI
  39. Niederberger, 2007, Antigens drive memory IgE responses in human allergy via the nasal mucosa, Int Arch Allergy Immunol, 142, 133, 10.1159/000096439 · DOI
  40. Mojtabavi, 2002, Long-lived Th2 memory in experimental allergic asthma, J Immunol, 169, 4788, 10.4049/jimmunol.169.9.4788 · DOI
  41. Kulig, 1999, Natural course of sensitization to food and inhalant allergens during the first 6 years of life, J Allergy Clin Immunol, 103, 1173, 10.1016/S0091-6749(99)70195-8 · DOI · Paper page
  42. Katelaris, 2012, Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America, Clin Exp Allergy, 42, 186, 10.1111/j.1365-2222.2011.03891.x · DOI
  43. Strobel, 2006, Oral tolerance and allergic responses to food proteins, Curr Opin Allergy Clin Immunol, 6, 207, 10.1097/01.all.0000225162.98391.81 · DOI
  44. Chehade, 2005, Oral tolerance and its relation to food hypersensitivities, J Allergy Clin Immunol, 115, 3, 10.1016/j.jaci.2004.11.008 · DOI
  45. Zhou, 2010, Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1, Nat Med, 16, 1128, 10.1038/nm.2201 · DOI
  46. Platzer, 2014, Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites, Mucosal Immunol
  47. Smith, 2008, Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+)CD127(lo/-) regulatory T cell function, J Allergy Clin Immunol, 121, 1460, 10.1016/j.jaci.2008.03.025 · DOI
  48. Karlsson, 2004, Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy, J Exp Med, 199, 1679, 10.1084/jem.20032121 · DOI
  49. Brandtzaeg, 2010, Food allergy: separating the science from the mythology, Nat Rev Gastroenterol Hepatol, 7, 380, 10.1038/nrgastro.2010.80 · DOI
  50. Egger, 2010, Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses, J Allergy Clin Immunol, 126, 1312, 10.1016/j.jaci.2010.06.008 · DOI
  51. Linhart, 2007, Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy, J Immunol, 178, 3924, 10.4049/jimmunol.178.6.3924 · DOI
  52. Marth, 2014, Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS, PLoS One, 9, e97893, 10.1371/journal.pone.0097893 · DOI
  53. Lupinek, 2012, Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults, J Allergy Clin Immunol, 130, 1418, 10.1016/j.jaci.2012.06.028 · DOI
  54. Hatzler, 2012, Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever, J Allergy Clin Immunol, 130, 894, 10.1016/j.jaci.2012.05.053 · DOI
  55. Durham, 1997, Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid, Eur J Immunol, 27, 2899, 10.1002/eji.1830271123 · DOI · Paper page
  56. Eckl-Dorna, 2012, The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells, Clin Exp Allergy, 42, 1347, 10.1111/j.1365-2222.2012.04030.x · DOI
  57. Burks, 2012, Oral immunotherapy for treatment of egg allergy in children, N Engl J Med, 367, 233, 10.1056/NEJMoa1200435 · DOI
  58. Nozawa, 2014, Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy, Pediatr Allergy Immunol, 25, 323, 10.1111/pai.12243 · DOI
  59. Sato, 2014, Clinical studies in oral allergen-specific immunotherapy: differences among allergens, Int Arch Allergy Immunol, 164, 1, 10.1159/000361025 · DOI
  60. Prescott, 2010, Avoidance or exposure to foods in prevention and treatment of food allergy?, Curr Opin Allergy Clin Immunol, 10, 258, 10.1097/ACI.0b013e328339ab25 · DOI
  61. Fisher, 2011, Specific oral tolerance induction in food allergic children: is oral desensitisation more effective than allergen avoidance?: a meta-analysis of published RCTs, Arch Dis Child, 96, 259, 10.1136/adc.2009.172460 · DOI
  62. Bischoff, 2005, Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives, Gastroenterology, 128, 1089, 10.1053/j.gastro.2004.08.015 · DOI
  63. Worm, 2014, Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland, Dtsch Arztebl Int, 111, 367
  64. Gieras, 2007, Molecular determinants of allergen-induced effector cell degranulation, J Allergy Clin Immunol, 119, 384, 10.1016/j.jaci.2006.09.034 · DOI
  65. Christensen, 2008, Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge, J Allergy Clin Immunol, 122, 298, 10.1016/j.jaci.2008.05.026 · DOI
  66. Dema, 2014, Rethinking the role of immunoglobulin E and its high-affinity receptor: new insights into allergy and beyond, Int Arch Allergy Immunol, 164, 271, 10.1159/000365633 · DOI
  67. MacGlashan, 1999, Upregulation of FcepsilonRI on human basophils by IgE antibody is mediated by interaction of IgE with FcepsilonRI, J Allergy Clin Immunol, 104, 492, 10.1016/S0091-6749(99)70399-4 · DOI
  68. Yamaguchi, 1999, J Immunol, 162, 5455, 10.4049/jimmunol.162.9.5455 · DOI
  69. Yunginger, 2000, Quantitative IgE antibody assays in allergic diseases, J Allergy Clin Immunol, 105, 1077, 10.1067/mai.2000.107041 · DOI
  70. Ahrens, 2012, Intestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice, Am J Pathol, 180, 1535, 10.1016/j.ajpath.2011.12.036 · DOI
  71. Reber, 2013, Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice, J Allergy Clin Immunol, 132, 881, 10.1016/j.jaci.2013.06.008 · DOI
  72. Hagel, 2013, Mast cell tryptase levels in gut mucosa in patients with gastrointestinal symptoms caused by food allergy, Int Arch Allergy Immunol, 160, 350, 10.1159/000341634 · DOI
  73. Burton, 2013, Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy, Mucosal Immunol, 6, 740, 10.1038/mi.2012.112 · DOI
  74. Charlesworth, 1989, Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration, J Clin Invest, 83, 1519, 10.1172/JCI114047 · DOI
  75. Charlesworth, 1991, Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen, J Immunol, 146, 671, 10.4049/jimmunol.146.2.671 · DOI
  76. Rothenberg, 2009, Biology and treatment of eosinophilic esophagitis, Gastroenterology, 137, 1238, 10.1053/j.gastro.2009.07.007 · DOI
  77. Noti, 2013, Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis, Nat Med, 19, 1005, 10.1038/nm.3281 · DOI
  78. Chu, 2014, Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo, J Exp Med, 211, 1657, 10.1084/jem.20131800 · DOI
  79. Novak, 2004, Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis, Curr Allergy Asthma Rep, 4, 263, 10.1007/s11882-004-0069-2 · DOI
  80. van Neerven, 2006, IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy, Int Arch Allergy Immunol, 141, 119, 10.1159/000094714 · DOI
  81. Haselden, 1999, Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions, J Exp Med, 189, 1885, 10.1084/jem.189.12.1885 · DOI
  82. Campana, 2008, Non-IgE-mediated chronic allergic skin inflammation revealed with rBet v 1 fragments, J Allergy Clin Immunol, 121, 528, 10.1016/j.jaci.2007.09.014 · DOI
  83. Reekers, 1996, The role of circulating food antigen-specific lymphocytes in food allergic children with atopic dermatitis, Br J Dermatol, 135, 935, 10.1046/j.1365-2133.1996.d01-1098.x · DOI
  84. Reisinger, 2005, IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation, J Allergy Clin Immunol, 115, 973, 10.1016/j.jaci.2005.01.021 · DOI
  85. Ebner, 1995, Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin), J Allergy Clin Immunol, 95, 962, 10.1016/S0091-6749(95)70096-X · DOI
  86. Kazemi-Shirazi, 2000, Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy, J Allergy Clin Immunol, 105, 116, 10.1016/S0091-6749(00)90186-6 · DOI
  87. Kleine-Tebbe, 2002, Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1- related PR-10 protein in soybean, SAM22, J Allergy Clin Immunol, 110, 797, 10.1067/mai.2002.128946 · DOI
  88. Bohle, 2006, Cooking birch pollen-related food: divergent consequences for IgE- and T cell-mediated reactivity in vitro and in vivo, J Allergy Clin Immunol, 118, 242, 10.1016/j.jaci.2006.03.011 · DOI · Paper page
  89. Reekers, 1999, Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens, J Allergy Clin Immunol, 104, 466, 10.1016/S0091-6749(99)70395-7 · DOI
  90. Muraro, 2014, EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy, Allergy, 69, 1008, 10.1111/all.12429 · DOI · Paper page
  91. Nermes, 2013, Is there a role for probiotics in the prevention or treatment of food allergy?, Curr Allergy Asthma Rep, 13, 622, 10.1007/s11882-013-0381-9 · DOI
  92. Osborn, 2013, Prebiotics in infants for prevention of allergy, Cochrane Database Syst Rev, 3, CD006474
  93. Rowe, 1928, Abdominal food allergy: its history, symptomatology, diagnosis and treatment, Cal West Med, 29, 317
  94. Lieberman, 2011, Diagnosis of food allergy: epicutaneous skin tests, in vitro tests, and oral food challenge, Curr Allergy Asthma Rep, 11, 58, 10.1007/s11882-010-0149-4 · DOI
  95. Gellerstedt, 2007, Methodological issues in the diagnostic work-up of food allergy: a real challenge, J Investig Allergol Clin Immunol, 17, 350
  96. Kvenshagen, 2013, The value of mucosal allergen challenge for the diagnosis of food allergy, Curr Opin Allergy Clin Immunol, 13, 268, 10.1097/ACI.0b013e32836093f6 · DOI
  97. Fiocchi, 2010, Diagnosis and rationale for action against cow's milk allergy (DRACMA): a summary report, J Allergy Clin Immunol, 126, 1119, 10.1016/j.jaci.2010.10.011 · DOI
  98. Larché, 2006, Immunological mechanisms of allergen-specific immunotherapy, Nat Rev Immunol, 6, 761, 10.1038/nri1934 · DOI
  99. Edwards, 1940, Oral desentitization in food allergy, Can Med Assoc J, 43, 234
  100. Valenta, 2010, From allergen genes to allergy vaccines, Annu Rev Immunol, 28, 211, 10.1146/annurev-immunol-030409-101218 · DOI
  101. Linhart, 2012, Vaccines for allergy, Curr Opin Immunol, 24, 354, 10.1016/j.coi.2012.03.006 · DOI
  102. Zuidmeer-Jongejan, 2012, FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies, Clin Transl Allergy, 2, 5, 10.1186/2045-7022-2-5 · DOI
  103. Fernández-Rivas, 2006, Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods, J Allergy Clin Immunol, 118, 481, 10.1016/j.jaci.2006.05.012 · DOI
  104. Vereda, 2011, Peanut allergy: clinical and immunologic differences among patients from 3 different geographic regions, J Allergy Clin Immunol, 127, 603, 10.1016/j.jaci.2010.09.010 · DOI
  105. Amoah, 2013, Peanut-specific IgE antibodies in asymptomatic Ghanaian children possibly caused by carbohydrate determinant cross-reactivity, J Allergy Clin Immunol, 132, 639, 10.1016/j.jaci.2013.04.023 · DOI
  106. Hochwallner, 2010, Microarray and allergenic activity assessment of milk allergens, Clin Exp Allergy, 40, 1809, 10.1111/j.1365-2222.2010.03602.x · DOI
  107. Constantin, 2009, Micro-arrayed wheat seed and grass pollen allergens for component-resolved diagnosis, Allergy, 64, 1030, 10.1111/j.1398-9995.2009.01955.x · DOI
  108. Radauer, 2014, Update of the WHO/IUIS Allergen Nomenclature Database based on analysis of allergen sequences, Allergy, 69, 413, 10.1111/all.12348 · DOI
  109. Breiteneder H, Mills C. Food allergens – molecular and immunological characteristics. In: Metcalfe DD, Sampson HA, Simon RA, et al, eds. Food allergy: adverse reactions to foods and food additives. 5th ed. Chichester, UK: John Wiley & Sons Ltd.
  110. Hiller, 2002, Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment, FASEB J, 16, 414, 10.1096/fj.01-0711fje · DOI
  111. Lupinek, 2014, Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip, Methods, 66, 106, 10.1016/j.ymeth.2013.10.008 · DOI
  112. Valenta, 2012, Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches, J Intern Med, 272, 144, 10.1111/j.1365-2796.2012.02556.x · DOI
  113. Focke, 2010, Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity, Clin Exp Allergy, 40, 385, 10.1111/j.1365-2222.2009.03443.x · DOI
  114. Valenta, 2011, Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens, Allergy, 66, 775, 10.1111/j.1398-9995.2011.02565.x · DOI
  115. Larché, 2011, T cell epitope-based allergy vaccines, Curr Top Microbiol Immunol, 352, 107
  116. Linhart, 2012, Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives, Vaccine, 30, 4328, 10.1016/j.vaccine.2011.11.011 · DOI
  117. Focke-Tejkl, 2012, Safety of engineered allergen-specific immunotherapy vaccines, Curr Opin Allergy Clin Immunol, 12, 555, 10.1097/ACI.0b013e328357ca53 · DOI
  118. Swoboda, 2007, A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy, J Immunol, 178, 6290, 10.4049/jimmunol.178.10.6290 · DOI
  119. Swoboda, 2013, A general strategy for the generation of hypoallergenic molecules for the immunotherapy of fish allergy, J Allergy Clin Immunol, 132, 979, 10.1016/j.jaci.2013.04.027 · DOI
  120. Uthoff, 2003, Critical role of preconceptional immunization for protective and nonpathological specific immunity in murine neonates, J Immunol, 171, 3485, 10.4049/jimmunol.171.7.3485 · DOI
  121. Flicker, 2011, Passive immunization with allergen-specific antibodies, Curr Top Microbiol Immunol, 352, 141
  122. von Berg, 2013, Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study, J Allergy Clin Immunol, 131, 1565, 10.1016/j.jaci.2013.01.006 · DOI
  123. Vriezinga, 2014, Randomized feeding intervention in infants at high risk for celiac disease, N Engl J Med, 371, 1304, 10.1056/NEJMoa1404172 · DOI
  124. Du Toit, 2013, Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study, J Allergy Clin Immunol, 131, 135, 10.1016/j.jaci.2012.09.015 · DOI
  125. Flicker, 2013, Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy, Immunobiology, 218, 884, 10.1016/j.imbio.2012.10.008 · DOI
  126. Jones, 2014, State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous, J Allergy Clin Immunol, 133, 318, 10.1016/j.jaci.2013.12.1040 · DOI
  127. Szépfalusi, 2014, Preventive sublingual immunotherapy in preschool children: first evidence for safety and pro-tolerogenic effects, Pediatr Allergy Immunol, 25, 788, 10.1111/pai.12310 · DOI
  128. Vickery, 2014, Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy, J Allergy Clin Immunol, 133, 468, 10.1016/j.jaci.2013.11.007 · DOI
  129. Rancitelli, 2011, Vaccine approaches for food allergy, Curr Top Microbiol Immunol, 352, 55

Cited by

Sorted by citations

Metadata

Authors
Valenta, R., Hochwallner, H., Linhart, B., & Pahr, S.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2015-05
Volume
148
Issue
6
Pages
1120-1131.e4
ISSN
0016-5085
DOI
10.1053/j.gastro.2015.02.006
PMC
PMC4414527
Cited by
277
References
9
Language
en
Licence
Funders
  • European Commission
  • Seventh Framework Programme
  • Christian Doppler Forschungsgesellschaft (201871)
  • Austrian Science Fund (P25921-B21, P23350-B11, F4605)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review